II. Efficacy
- Significantly reduces allergic symptoms
- Reduces nasal obstruction
- Reduces Rhinorrhea, sneezing, and nasal itching
- More effective than Antihistamines
- Small effect on impaired smell
- References
III. Safety
- Pregnancy Category: C (except Budesonide which is pregnancy category B)
- Systemic absorption is minimal
- Appears safe in children as young as age 2 years
- No hypothalamic-pituitary-adrenal axis suppression
- Galant (2003) Pediatrics 112:96-100 [PubMed]
IV. Pharmacokinetics
- Onset of action within hours, but maximal effect requires 2-4 weeks of continuous use
V. Adverse Effects
- Bitter aftertaste
- Candidiasis
- Nasal irritation
- Pharyngitis or Dry Mouth
- Nasal septum perforation (rare)
-
Epistaxis
- Reduced by spraying away from septum
- Use left hand when spraying right nostril
- Use right hand when spraying left nostril
- (2004) Prescribers Letter 11(1):2 [PubMed]
VI. General
VII. Preparations: By Age Restriction
- All agents are pregnancy category C (except Budesonide which is pregnancy category B)
- Age 2 years and older
- Intranasal Fluticasone furoate (Veramyst, Flonase sensimist)
- Intranasal Mometasone (Nosonex)
- Intranasal Triamcinolone (Nasocort)
- Age 4 years and older
- Age 6 years and older
- Intranasal Beclomethasone (Beconase, Qnasl, Pregnancy category B)
- Intranasal Budesonide (Rhinocort)
- Intranasal Ciclesonide (Omnaris)
- Intranasal Flunisolide
VIII. Preparations: Low potency agents (especially in children)
-
Intranasal Triamcinolone acetonide (Nasacort)
- As of 2014, available as OTC ($20 per 120 spray bottle)
- Relative potency: 1
- Dose (age 2 years and older)
- Child: 1 sprays per nostril daily
- Adult: 2 sprays per nostril daily (then taper to 1 spray per nostril daily as able)
-
Intranasal Mometasone (Nasonex)
- Dose (2 years and older): 1 spray each nostril daily (adults should use 2 sprays each nostril)
- Relative potency: 1
- OTC in 2022
IX. Preparations: Medium potency agents
-
Intranasal Flunisolide (Nasalide)
- Dose: 2 sprays per nostril twice daily
- Relative potency: 3
- Age 6 years and older
-
Intranasal Beclomethasone (Beclovent)
- Dose (age 6 and older): 1-2 sprays per nostril twice daily
- Relative potency: 5
- Pregnancy Category C
X. Preparations: Higher potency agents
-
Intranasal Budesonide (Rhinocort)
- As of 2016, over-ther-counter without a prescription
- Dose (age 6 to older): 1-2 sprays each nostril daily
- Adults may bolus start with 4 sprays/nostril daily for 1 week then use standard dose (1-2 sprays)
- Relative potency: 10
- Pregnancy Category B
-
Intranasal Fluticasone Propionate (Flonase)
- As of 2015, over-ther-counter without a prescription
- Dose (age 4 years and older): 1-2 sprays per nostril daily
- Relative potency: 10
- Intranasal Qvar 80 mg (use oral Inhaler with baby bottle nipple as nasal adapter)
- Dose: 1-2 sprays each nostril daily
- Intranasal Ciclesonide (Omnaris, Zetonna)
XI. Preparations: Miscellaneous
- Combination Agents
- Fluticasone with Azelastine (Dymista)
- Expensive (up to $200/month) and add little to benefit of generic nasal Corticosteroids alone
- Alternatively, use OTC Azelastine (Astepro) and a generic generic nasal Corticosteroid
- (2022) Presc Lett 29(5): 25-6
- Fluticasone with Azelastine (Dymista)
-
Xhance (fluticasone nose and mouth device, for Nasal Polyps)
- Patient blows into mouth piece while activating device 93 mcg bid
- Theoretically penetrates more deeply into nose (hence reaching Nasal Polyps)
- Unproven benefit and expensive ($425/month in 2018)
- Similar effect likely with Nasal Saline pre-treatment and 2 standard fluticasone sprays bid
- (2018) Presc Lett 25(7): 41